Strategic rationale
A foundational principle for medicines security
Decision-makers must be able to trust both MSI's analysis and the conditions under which it was produced. The Institute is developing safeguards for funding, conflicts of interest, methodology, peer scrutiny and publication so that evidence and conclusions remain free from inappropriate influence.
How MSI applies this principle
- Protect editorial and analytical freedom
- Disclose material interests and funding relationships
- Publish methods, limitations and correction procedures
- Separate institutional support from research conclusions